Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

49 Views

C4. Respiratory infections - viral

Poster Session: Respiratory Infections: Viral and Bacterial

(P-642) Attributes of Point-of-Care Nucleic Acid Amplification Tests for Respiratory Syncytial Virus (RSV): Results of a Systematic Literature Review

Monday, October 20, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Kashmira Date, MD. MPH

Senior Director, Global Medical Affairs
Pfizer, Inc.
Atlanta, GA, United States

KF

Kyle Fowler, PhD

Principal Scientist
Pfizer
San Francisco, California, United States
KP

Katherine Perez, PhD

Pfizer, Inc.
Groton, Connecticut, United States
ST

Sima S. Toussi, MD

Pfizer Inc.
New York, New York, United States
Mary Lynn Baniecki, PhD

Head of Infectious Disease for Translational Medicine
Pfizer Inc
Cambridge, Massachusetts, United States
ET

Elaine Thomas, PhD

Pfizer
London, England, United Kingdom
KS

Katherine Schneider, PhD

Associate Director
Pfizer
Pearl River, New York, United States
OR

Ornella Ruiz, MD, MSc

Epidemiologist
P-95
Barranquilla, Colombia, Atlantico, Colombia
SS

Suzie Seabroke, PhD MSc BSc

Senior Epidemiologist
P95
Leuven, Vlaams-Brabant, Belgium
BG

Bradford D. Gessner, MD, MPH

Sole Proprietor
EpiVac Consulting
Anchorage, Alaska, United States
Elizabeth Begier, MD, M.P.H.

Senior Director, Scientific Affairs Lead, RSV Antiviral/Adult Vaccine Program
Pfizer Vaccines
Dublin, Dublin, Ireland